Dept reviews PBAC's cost-minimisation process

The Department of Health, Disability and Ageing will undertake a rapid review of PBS-listed relapsing-remitting multiple sclerosis drugs, including how they are being used and whether the PBAC needs to change how it compares them.

To see the whole article, log in or create an account.

James Quintana Pearce